PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.08 and traded as high as $0.09. PURE Bioscience shares last traded at $0.09, with a volume of 47,925 shares trading hands.
PURE Bioscience Stock Up 1.8 %
The firm has a market capitalization of $10.07 million, a P/E ratio of -2.25 and a beta of 0.35. The company’s 50 day moving average is $0.07 and its 200-day moving average is $0.08.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its quarterly earnings results on Monday, March 17th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.39 million for the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- What Investors Need to Know About Upcoming IPOs
- Energy Transfer: Powering Data With Dividends and Diversification
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Qualcomm Stock Is Coiling for a Breakout
- Top Biotech Stocks: Exploring Innovation Opportunities
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
